182 related articles for article (PubMed ID: 9834205)
1. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.
Döhner K; Brown J; Hehmann U; Hetzel C; Stewart J; Lowther G; Scholl C; Fröhling S; Cuneo A; Tsui LC; Lichter P; Scherer SW; Döhner H
Blood; 1998 Dec; 92(11):4031-5. PubMed ID: 9834205
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
[TBL] [Abstract][Full Text] [Related]
4. Delineation of multiple deleted regions in 7q in myeloid disorders.
Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
[TBL] [Abstract][Full Text] [Related]
6. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
8. Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines.
De Weer A; Poppe B; Vergult S; Van Vlierberghe P; Petrick M; De Bock R; Benoit Y; Noens L; De Paepe A; Van Roy N; Menten B; Speleman F
PLoS One; 2010 Jan; 5(1):e8676. PubMed ID: 20084277
[TBL] [Abstract][Full Text] [Related]
9. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672
[TBL] [Abstract][Full Text] [Related]
10. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
11. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
12. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
Wang PW; Eisenbart JD; Espinosa R; Davis EM; Larson RA; Le Beau MM
Genomics; 2000 Jul; 67(1):28-39. PubMed ID: 10945467
[TBL] [Abstract][Full Text] [Related]
13. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
14. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
15. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
[TBL] [Abstract][Full Text] [Related]
17. t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
Slater RM; von Drunen E; Kroes WG; Weghuis DO; van den Berg E; Smit EM; van der Does-van den Berg A; van Wering E; Hählen K; Carroll AJ; Raimondi SC; Beverloo HB
Leukemia; 2001 Jun; 15(6):915-20. PubMed ID: 11417477
[TBL] [Abstract][Full Text] [Related]
18. Activation of EVI1 transcripts with chromosomal translocation joining the TCRVbeta locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8).
Suzukawa K; Kodera T; Shimizu S; Nagasawa T; Asou H; Kamada N; Taniwaki M; Yokota J; Morishita K
Leukemia; 1999 Sep; 13(9):1359-66. PubMed ID: 10482986
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
Stilgenbauer S; Liebisch P; James MR; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11837-41. PubMed ID: 8876224
[TBL] [Abstract][Full Text] [Related]
20. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
